SCHEMBL5135294

SCHEMBL5135294

CCCCn1c(-c2ccccc2)nc(-c2ccccc2)c1CN(Cc1ccc(O)c(CO)c1)CC1CCCCC1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
C5AR1 P21730 1/20 0.44
BCHE P06276 4/20 0.38
ACHE P22303 1/20 0.38
HDAC1 Q13547 1/20 0.34
TSHR P16473 2/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP3A4 P08684 1/20 0.33
HPGD P15428 1/20 0.33
HSD17B10 Q99714 1/20 0.33
OPRM1 P35372 4/20 0.33
OPRK1 P41145 4/20 0.33
LTB4R2 Q9NPC1 1/20 0.32
AVPR1B P47901 1/20 0.32
CCR4 P51679 1/20 0.32
OPRD1 P41143 2/20 0.32
CRHR1 P34998 1/20 0.32
ABCC1 P33527 1/20 0.31
AGTR1 P30556 1/20 0.31
PPARG P37231 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4763715 0.91 C5AR1 (0.46) C5AR1BCHEACHEHDAC1TSHR
SCHEMBL5135330 0.90 C5AR1 (0.43) C5AR1BCHEACHEHDAC1TSHR
SCHEMBL651431 0.90 C5AR1 (0.43) C5AR1BCHEACHEHDAC1TSHR
SCHEMBL5134718 0.89 C5AR1 (0.43) C5AR1BCHEHDAC1TSHRKDM4E
SCHEMBL5135268 0.88 C5AR1 (0.42) C5AR1BCHEACHEHDAC1LTB4R2
SCHEMBL5136793 0.88 C5AR1 (0.41) C5AR1BCHEACHEHDAC1TSHR
SCHEMBL5135130 0.87 C5AR1 (0.48) C5AR1BCHETSHRKDM4EALDH1A1
SCHEMBL5072432 0.87 C5AR1 (0.47) C5AR1BCHEHDAC1TSHRKDM4E
SCHEMBL5135713 0.86 C5AR1 (0.44) C5AR1HDAC1TSHRKDM4EALDH1A1
SCHEMBL5137864 0.86 C5AR1 (0.44) C5AR1BCHEHDAC1TSHRKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1490044-A4 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORP (US) 2008-04-16 EP disclosed
EP-1490044-A1 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORPORATION (US) 2004-12-29 EP disclosed
WO-2003084524-A1 COMBINATION THERAPY FOR THE TREATMENT OF CONDITIONS WITH PATHOGENIC INFLAMMATORY COMPONENTS NEUROGEN CORPORATION (US) 2003-10-16 WO disclosed